Health Condition 1: null- Acute pain in Herpes Zoster
Conditions
Interventions
Intervention1: Valacyclovir (1gm Tds x 7days) with pregabalin(75mg bd x 1 month) and Valacyclovir(1gm Tds x 7days),Pregabalin pregabalin(75mg bd x 1 month) with Methyprednisolone (16mg bd x 7 days):
Sponsors
Dr sanjiv choudhary
No sponsor
Eligibility
Inclusion criteria
Inclusion criteria: 1) All patients of Herpes zoster of eruptions less than 72 hours duration. 2) Patients with age group 18 years to 70 years of both genders. 3) Patients willing to participate 3) Herpes zoster ophthalmicus without corneal involvement.
Exclusion criteria
Exclusion criteria: 1) Herpes zoster in pregnant and lactating patients. 2) Age less than 18 years and more than 70 years. 3) Herpes zoster ophthalmicus with keratitis. 4) Herpes zoster patients with diabetes mellitus, hypertension, tuberculosis, gastro-intestinal ulcer disease or with immune-compromised condition 5) Cases of disseminated Herpes zoster infection. 6) Patients of cardiac arrhythmia and cardiac disease 7) Patient with known hypersensitivity for drugs over study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in the severity of pain both in percentage (100-76%: excellent, 75-51%: good, 50-26%: moderate, 25% and less: poor) and grade (mild-pain perceived but day activities and night sleep not affected, moderate- day activities not affected but night sleep affected, severe-both day activities and night sleep affected) was noted. Timepoint: measured at end of 1, 4, 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients were monitored for side-effects during follow up period.Timepoint: monitored at end of 1, 4, 6 weeks | — |
Countries
India
Contacts
Public ContactDr Sanjiv Choudhary
DMIMS
Outcome results
None listed